Cheryl B Lin
Overview
Explore the profile of Cheryl B Lin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
131
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang B, Pei T, Lin C, Guo R, Elashoff D, Lin J, et al.
World J Crit Care Med
. 2018 Sep;
7(4):46-51.
PMID: 30211019
Aim: To characterize the clinical course and outcomes of nasal intermittent mandatory ventilation (NIMV) use in acute pediatric respiratory failure. Methods: We identified all patients treated with NIMV in the...
2.
Lin C, Cox M, Olson D, Britz G, Constable M, Fonarow G, et al.
J Am Heart Assoc
. 2015 Jul;
4(7).
PMID: 26201547
Background: Timely thrombolytic therapy can improve stroke outcomes. Nevertheless, the ability of US hospitals to meet guidelines for intravenous tissue plasminogen activator (tPA) remains suboptimal. What is unclear is whether...
3.
Olson D, Cox M, Constable M, Britz G, Lin C, Zimmer L, et al.
J Neurosci Nurs
. 2014 Aug;
46(5):267-73.
PMID: 25099063
No instruments are currently available to help health systems identify target areas for reducing door-to-needle times for the administration of intravenous tissue plasminogen activator to eligible patients with ischemic stroke....
4.
Lin C, Peterson E, Smith E, Saver J, Liang L, Xian Y, et al.
J Am Heart Assoc
. 2012 Nov;
1(4):e002345.
PMID: 23130167
BACKGROUND#ENTITYSTARTX02014;: Emergency medical services (EMS) hospital prenotification of an incoming stroke patient is guideline recommended as a means of increasing the timeliness with which stroke patients are evaluated and treated....
5.
Lin C, Hornik C, Clark R, Cotten C, Benjamin Jr D, Cohen-Wolkoweiz M, et al.
Early Hum Dev
. 2012 Jul;
88(11):905-9.
PMID: 22840605
Background: Very low birth weight neonates (≤ 1500 g, VLBWs) have a high rate of infection and distinct baseline immune function compared with more mature populations. In critically ill children...
6.
Lin C, Peterson E, Smith E, Saver J, Liang L, Xian Y, et al.
Circ Cardiovasc Qual Outcomes
. 2012 Jul;
5(4):514-22.
PMID: 22787065
Background: The benefits of intravenous tissue-plasminogen activator (tPA) in acute ischemic stroke are time-dependent. Emergency medical services (EMS) hospital prenotification of an incoming patient with potential stroke may provide a...
7.
Olson D, Constable M, Britz G, Lin C, Zimmer L, Schwamm L, et al.
J Neurosci Nurs
. 2011 Nov;
43(6):329-36.
PMID: 22089410
Early treatment with intravenous (IV) recombinant tissue plasminogen activator/alteplase (tPA) is associated with improved outcomes for patients with an acute ischemic stroke. Thus, rapid triage and treatment of stroke patients...